开能健康: 关于提前赎回开能转债的第八次提示性公告

Core Viewpoint - The company has triggered the conditional redemption clause for its convertible bonds due to the stock price exceeding 130% of the conversion price, leading to an early redemption decision by the board of directors [2][3][6]. Group 1: Convertible Bond Details - The company issued 2.5 million convertible bonds with a total value of 250 million yuan, each with a face value of 100 yuan [2]. - The initial conversion price was set at 5.67 yuan per share, which has been adjusted multiple times due to dividend distributions, with the latest adjustment bringing it to 5.36 yuan per share [3][5][6]. - The bonds have a maturity period from July 20, 2023, to July 19, 2029, with a tiered interest rate structure starting at 0.30% in the first year and reaching 3.00% in the sixth year [6]. Group 2: Redemption Conditions and Procedures - The conditional redemption clause allows the company to redeem the bonds if the stock price remains above 6.968 yuan (130% of the conversion price) for at least 15 out of 30 consecutive trading days [2][6]. - The redemption price is set at 100.118 yuan per bond, which includes accrued interest calculated based on the bond's face value and interest rate [6][8]. - The redemption process will be completed by September 2, 2025, with funds transferred to bondholders' accounts on September 9, 2025 [8]. Group 3: Investor Advisory - Investors are advised to be aware of the risks associated with the inability to convert bonds if they are pledged or frozen before the conversion deadline [1][2]. - The company emphasizes the importance of timely action by bondholders to avoid potential losses due to the redemption process [1][2].